close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by BostonGene Corporation

News headline image
BostonGene Announces Collaboration with Ottimo Pharma to Optimize and Accelerate Development of First-in-Class PD-1/VEGFR2 Immuno-Oncology Therapy Using AI
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Sylvester Comprehensive Cancer Center to Showcase Omnimodal AI Clinical Trial Innovations at Association for Molecular Pathology 2025 Annual Meeting & Expo
From BostonGene Corporation
Via Business Wire
News headline image
Study Published in Cell Reports Medicine Showcases BostonGene’s Multimodal AI Solutions to Stratify PD-1 and VEGF Immunotherapy Outcomes in Kidney Cancer
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Showcase its Multimodal AI Platform Advancing Drug Development at the 2025 ASCO® Annual Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BioTech Breakthrough Awards BostonGene With “Cancer Immunology Solution of the Year”
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in Friends of Cancer Research Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in The Festival of Genomics & Biodata 2025
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Drive Value-Based Cancer Care Discussions at the 14th Annual AVBCC Summit and Educational Program
From BostonGene Corporation
Via Business Wire
News headline image
GlobalData Awards BostonGene with Four Clinical Trials Arena Excellence Awards
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Participate in the European Federation of Laboratory Medicine Strategic Conference 2024
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Leading Global Cancer Institutions Announce Nature Publication
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Acceptance of Three Abstracts for Presentation at ESMO Congress 2024
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Honored as Gold and Silver Stevie® Award Winner in 2024 Stevie Awards for Technology Excellence
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Mount Sinai to Collaborate on a Prospective Precision Medicine Study of Patients with Multiple Myeloma
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Showcases AI-Powered Multiomics Platform and Advances in Immune System Profiling at 14th World Clinical Biomarkers & CDx Summit
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Collaborators Honored with GRASP Advocate Choice Award at the 2024 ASCO Annual Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Publication and Journal Cover Feature in Cancer Cell that Unveils a New Immune System Profiling Platform Stratifying Cancer Patients by Treatment Response
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Recognized as Designated Laboratory for the ComboMATCH Precision Medicine Clinical Trial
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Participation at the United States and Canadian Academy of Pathology 113th Annual Meeting
From BostonGene Corporation
Via Business Wire
News headline image
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Announces Publication in Nature
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Prisma Health Announce Collaboration Aimed at Predicting Efficacy of Immunotherapy in Rare Cancers
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Named to the 2023 CB Insights' Digital Health 50 List
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s 2023 Annual Meeting
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene and Hokkaido University Hospital Collaborate to Develop Novel HER2 Protocols for Breast Cancer
From BostonGene Corporation
Via Business Wire
News headline image
Patient Advocacy Group Awards BostonGene and Its Collaborators a GRASP Advocate Choice Award for 2023 ASCO Annual Meeting Poster
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene Highlights Approach to IO Research and Precision Medicine at the 6th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference
From BostonGene Corporation
Via Business Wire
News headline image
BostonGene to Showcase Integrated Approach to Precision Medicine at PEGS Boston 2023
From BostonGene Corporation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today